Internal Medicine · Philadelphia, PA
NPI
1023558400
Since 2017
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
101 E Olney Ave Ste C5
Philadelphia, PA, 19120
Phone (215) 927-1937
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
544 services
Medicare patients, 2024
183
Average age 68
Drug cost, 2024
$3.3M
23,462 prescriptions
Company payments, 2025
$3,244
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William C Heppenstall was code 99214 (office e&m - established), 397 times for 174 patients. In total William C Heppenstall billed 544 services in 15 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 397 | 174 | $88.48 | $35K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 61 | 61 | $140.82 | $8,590 |
| 99213 Office E&M - Established | Office | 22 | 18 | $56.34 | $1,239 |
| G0008 Administration of influenza virus vaccine | Office | 16 | 16 | $33.29 | $533 |
| 90653 Vaccine Product | Office | 12 | 12 | $81.82 | $982 |
By year: 2022 $26K for 459 services; 2023 $27K for 576 services; 2024 $49K for 544 services.
Medicare prescription drug claims, 2024
In 2024, the drug William C Heppenstall prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,396 prescriptions and refills. In total William C Heppenstall wrote 23,462 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,396 | 3,404 | 364 | $23K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 793 | 856 | 153 | $24K |
| Amlodipine Besylate Generic | 700 | 1,690 | 186 | $5,322 |
| Gabapentin Generic | 687 | 1,153 | 142 | $12K |
| Losartan Potassium Generic | 641 | 1,505 | 152 | $7,604 |
| Fluticasone Propionate Generic | 578 | 840 | 155 | $8,034 |
| Metformin Hcl Generic | 572 | 1,333 | 146 | $4,677 |
| Pantoprazole Sodium Generic | 514 | 1,054 | 114 | $7,166 |
| Omeprazole Generic | 487 | 1,134 | 138 | $5,408 |
| Hydrochlorothiazide Generic | 452 | 1,031 | 125 | $1,306 |
| Carvedilol Generic | 426 | 956 | 113 | $4,848 |
| Nifedipine Er Nifedipine | 367 | 832 | 91 | $11K |
| Farxiga Dapagliflozin Propanediol | 362 | 635 | 82 | $349K |
| Rosuvastatin Calcium Generic | 357 | 813 | 93 | $8,694 |
| Montelukast Sodium Generic | 354 | 651 | 74 | $4,894 |
Brand drugs: 4,279 claims; generic drugs: 18,830 claims; opioid claims: 318.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William C Heppenstall $3,244 ($3,244 in general payments such as food, travel and fees) from 22 companies. The largest payer was Abbvie Inc. with $670.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 39 | $670 |
| Pfizer Inc. PFE | 17 | $332 |
| Novo Nordisk Inc NVO | 13 | $300 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $224 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $197 |
| Lilly USA, LLC LLY | 9 | $186 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 9 | $185 |
| Exact Sciences Corporation EXAS | 7 | $162 |
| Astellas Pharma US Inc 4503.T | 5 | $147 |
| GlaxoSmithKline, LLC. GSK | 6 | $141 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.